Skip to content

Pulmonary rehabilitation in sputum positive TB patients

Effect of Pulmonary rehabilitation on the exercise tolerance in sputum positive pulmonary TB patients - TB, PR

Status
Active, not recruiting
Phases
Phase 3Phase 4
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/02/062383
Enrollment
240
Registered
2024-02-07
Start date
Unknown
Completion date
Unknown
Last updated
2024-03-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: A150- Tuberculosis of lung

Interventions

Intervention1: PULMONARY REHABILITATION: In addition to usual care described above, participants in the intervention arm will receive PR. 16-week outpatient program 2 days in a week for 8 weeks in Ou

Sponsors

ICMR INTRAMURAL FUNDING
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.aged =18 years, 2.willing and able to provide written informed consent 3.a documented history of smear positive pulmonary TB with treatment initiated at selected NTEP centres with smear negative status during the Intensive Phase 4.A report of Medical Research Council (MRC) dyspnoea grade =2

Exclusion criteria

Exclusion criteria: 1. Previous episode of TB treatment 2. any skeletal deformity that intervenes with physical exercises. 3. unwilling to participate for any reason

Design outcomes

Primary

MeasureTime frame
1.Primary Outcome: -A change in walking distance measured by the 6 MWT pre-intervention to post-intervention. 2. Secondary Outcome: -Measurement of association between lung function impairment and radiological changes -Proportion of participants with optimal respiratory health status Timepoint: at baseline and at the end of TB treatment

Secondary

MeasureTime frame
Secondary Outcome: -Measurement of association between lung function impairment & radiological changes -Proportion of participants with optimal respiratory health status Timepoint: at baseline, at end of TB treatment, at 6 months interval for 2 years

Countries

India

Contacts

Public ContactDr Poorana Ganga Devi

Indian Council of Medical Research National Institute for Research in Tuberculosis

drpooranadevi@yahoo.co.in9487260546

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026